IRCWF yields 14492.75% · JNJ yields 2.14%● Live data
📍 IRCWF pulled ahead of the other in Year 1
Combined, IRCWF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IRCWF + JNJ for your $10,000?
IRC Limited, an investment holding company, develops, produces, and sells industrial commodities products in the Russia, People's Republic of China, and internationally. The company operates through four segments: Mines in Production, Mines in Development, Engineering, and Other. The Mines in Production segment comprises iron ore projects in production phase, which include the Kimkan and Sutara project located in the Obluchenskoye district of the Jewish Autonomous Region in the Russian Far East. The Mines in Development segment consists of iron ore projects in the exploration and development phase comprising the Garinskoye project that focuses on iron ore deposits in the Amur region; Kostenginskoye project; and the Bolshoi Seym project that explores for ilmenomagnetite, magnetite, and ilmenite located in the located in the Tynda district of Amur region in the Russian Far East region. The Engineering segment provides technical mining research and consultancy services. The Other segment engages in the production of vanadium pentoxides and related products, and other projects. It is also involved in the provision of general trading, financing, engineering, and procurement services; and development of titanium sponge. The company was incorporated in 2010 and is headquartered in Central, Hong Kong.
Full IRCWF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.